Acumen Pharmaceuticals (ABOS)

• Market cap: $124M
• 1 day: -4.21%
• 5 days: 7.89%
• 1 month: 29.75%
• 3 months: 62.7%
• 6 months: 79.82%
• Year to date: 10.81%
• 1 year: 4.06%
• 5 years: -89.8%
• 10 years: -89.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Employees: 52